SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending as traders focus on the company's upcoming quarterly earnings report, with sentiment divided between expectations of strong AI-server demand and concerns about broader tech sector weakness. The community is closely watching the company's commentary on backlog and margins, which is seen as a key read-through for the AI infrastructure market.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple shares are trending amid a leadership transition as John Ternus officially succeeds Tim Cook as CEO, while the company also faces news of a trade-secret lawsuit against OpenAI. Traders are closely watching these developments ahead of an upcoming product launch event, with sentiment split between optimism over the new leadership and skepticism regarding the stock's recent valuation.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending as traders react to heightened tensions in the Middle East, specifically reports of military strikes by U.S. forces against targets in the Strait of Hormuz. The community remains divided, with some traders debating potential supply disruptions and bullish price impacts, while others express skepticism over market manipulation and the sustainability of current oil price levels.

PG&E Corp. operates as a holding company, which engages in generation, transmission, and distribution of electricity and natural gas to customers. It specializes in energy, utility, power, gas, electricity, solar, and sustainability. The company was founded on November 17, 1995 and is headquartered in Oakland, CA.

PG&E Corp.

PCG is seeing heightened activity driven by a combination of institutional options speculation and uncertainty surrounding potential wildfire liability risks in California. While some investors are betting on a recovery supported by demand for grid infrastructure and data center energy, others remain cautious due to ongoing regulatory pressures and wildfire-related volatility.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Traders are closely monitoring rising oil prices and bond yields, which were spurred by news of U.S. strikes against Iranian targets in the Strait of Hormuz. Despite initial selling, the community is debating whether this marks a sustainable market decline or if, as many traders argue, it is an opportunity to buy the dip following a pattern of market resilience.

Fervo Energy Co. operates as a energy company. It builds and operates power facilities in extracting geothermal energy. The company was founded by Jack Norbeck and Timothy Latimer in 2017 and is headquartered in Berkeley, CA.

Fervo Energy Co. - Ordinary Shares - Class A

Fervo Energy Co

Fervo Energy is trending following the announcement of a major power purchase agreement with Google to supply geothermal energy for potential data center development. While some traders view the deal as a significant fundamental de-risking event that validates the company's utility-scale commercial model, others remain skeptical, citing concerns over future dilution, lack of current profitability, and the long timeline before projects become operational.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology is experiencing heightened volatility and selling pressure as traders react to broad market macro concerns and speculation regarding potential U.S. restrictions on Chinese optical transceiver components. While some investors remain cautious about customer concentration and sector-wide headwinds, many see the price drop as a buying opportunity, citing the company's strong fundamentals and growth potential within the AI data center infrastructure market.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trading lower as traders express concern over the company's valuation, high price-to-earnings multiples, and skepticism regarding its recent market rally. The conversation is fragmented, with some participants citing potential manipulation and profit-taking ahead of upcoming earnings, while others debate the long-term impact of AI on cybersecurity demand.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is trending as traders speculate on a potential price breakout ahead of earnings, with many anticipating a recovery toward historical highs despite ongoing concerns regarding macroeconomic pressures and short-selling activity. The sentiment remains divided, characterized by a mix of long-term conviction in the company’s business consolidation strategy and frustration over recent volatility and dilution.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike shares declined following the company's financial report, with traders expressing concerns over the company's valuation metrics and the disconnect between GAAP and non-GAAP figures despite beating quarterly earnings estimates. While some community members highlight the positive long-term potential of the firm's AI-driven cybersecurity partnerships, many are focused on the stock's volatility and its premium valuation compared to industry peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can LQDA's Yutrepia Sustain Growth Amid Fierce PAH Competition?

Liquidia's Yutrepia is driving rapid growth, but fierce PAH competition and new pipeline therapies could challenge its momentum.

If You Invested $1000 In Insmed Stock 10 Years Ago, You Would Have This Much Today

Insmed (NASDAQ:INSM) has outperformed the market over the past 10 years by 10.74% on an annualized basis producing an average annual return of 24.29%. Currently, Insmed has a market capitalization of $26.34 billion.read more...

Liquidia vs. Insmed: Which Pulmonary Stock Has Better Prospects Now?

Liquidia's Yutrepia is driving strong growth, but Insmed's Brinsupri and broader pipeline could make it the better long-term pick.

Insmed to Present at September 2026 Investor Conferences

Insmed to Present at September 2026 Investor Conferences Insmed to Present at September 2026 Investor Conferences PR Newswire BRIDGEWATER, N.J., Aug. 26, 2026 BRIDGEWATER, N.J., Aug. 26, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company...

BRINSUPRI (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease

BRINSUPRI (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease BRINSUPRI (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients...

Top Analyst Reports for Visa, Lam Research & Caterpillar

Visa's payments growth, Lam Research's AI-driven demand and Caterpillar's broad market momentum headline today's top analyst reports.

Insmed (INSM) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

$1000 Invested In Insmed 5 Years Ago Would Be Worth This Much Today

Insmed (NASDAQ:INSM) has outperformed the market over the past 5 years by 29.76% on an annualized basis producing an average annual return of 41.43%. Currently, Insmed has a market capitalization of $28.82 billion.read more...

What Insmed Stock's Premium Is Actually Buying

What Insmed Stock's Premium Is Actually Buying...

Insmed Tops Q2 Earnings Estimates, Stock Soars 34% on Brinsupri Uptake

INSM tops Q2 revenue and earnings estimates as strong Brinsupri uptake drives a 34% stock jump and prompts sharply higher 2026 sales guidance.

• Reported GAAP EPS of -$0.06 up 96.47% YoY
• Reported revenue of $425.49M up 296.11% YoY
• Insmed raised its 2026 BRINSUPRI revenue guidance to a range of $1.25 billion to $1.40 billion and reiterated its 2026 ARIKAYCE revenue guidance of $450 million to $470 million for the company.

Insmed recorded a net loss of $13.2 million while experiencing increased operating expenses, alongside potential regulatory and policy uncertainties that may impact the future timing of international commercial product launches.

Insmed raised its peak revenue estimates to over $14 billion for its lead programs, supported by strong BRINSUPRI revenue growth and positive clinical data reinforcing the potential of its TPIP pipeline.

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Insmed Inc

INSM Stock Dips In Extended Trading After Experimental Skin Disease Drug Fails In Study 

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

INSM Insmed Inc

Fundamentals

Latest INSM News